How many institutions own GENB stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own GENB shares is 76, representing 76.08% of the company's common stock.

Who are the major shareholders selling Generate Biomedicines, Inc. stock?

N/A, in the last quarter, reduced its stake in GENB by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the GENB shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned GENB shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying GENB stock?

As per its latest 13F filing, MILLENNIUM MANAGEMENT LLC increased its stake in GENB by 100% in the last quarter. The institutional holder raised its holding to 376.89 thousand shares having worth more than $4.71M. AMERIPRISE FINANCIAL INC also added 100% more shares of GENB to its portfolio, raising its holding to 87.34 thousand shares of worth $1.09M. BALYASNY ASSET MANAGEMENT L.P. also increased its GENB shares holding by 100% which brought its holding to 79.49 thousand shares worth $993.61K.

GENB's major insiders: who are they?

The insider with the most stakes in GENB is N/A , N/A at the company. Additionally, GENB stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell GENB stock?

Company executives, directors, and other insiders own 14.07% percent of Generate Biomedicines, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which GENB insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased GENB stock?

There have been 0 transaction(s) during the past 6-months in which Generate Biomedicines, Inc. insiders have bought stock, totalling 0 shares

How much of GENB does insiders own?

Around 0 Generate Biomedicines, Inc. shares are held by insiders, which represents about 14.07% of GENB stock.

Who is the insider with the largest stake?

GENB N/A, N/A holds the largest portfolio of the company's shares. GENB shares owned by N/A total nearly -.

Which institution holds the most shares in GENB?

MILLENNIUM MANAGEMENT LLC is the largest institutional owner in GENB which holds 376.89 thousand shares worth $4.71M or 0.29% of the total GENB shares outstanding followed by AMERIPRISE FINANCIAL INC with ownership of 87.34 thousand shares representing 0.07% of the GENB ownership. BALYASNY ASSET MANAGEMENT L.P. is the third largest stakeholder with 79.49 thousand shares or 0.06% of the ownership worth more than $993.61K.

Is Generate Biomedicines, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the GENB is concerned, it is a stock which is not optionable.

Is there a short position on GENB's shares?

Number of GENB shares short is 6.99M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding GENB shares are there?

As of today, 128.19M shares of GENB are outstanding.

Is there many float in GENB stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, GENB has 60.29M shares in float.

GENB short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for GENB is 6.4.

Generate Biomedicines (GENB) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares5.45

Short Percent Of Float9.36

Shares Outstanding128.19M

Shares Float60.29M

Shares Short6.99M

Short Ratio6.4

9.36%

Short % of Float

5.45%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

14.07% Percentage of Shares held by All Insiders

76.08% Percentage of Shares held by All Institutions

88.54% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 76.08% of GENB shares are held by financial institutions. MILLENNIUM MANAGEMENT LLC is the top corporate investor, holding 376.89K shares valued at $4.71M. A 0.29% stake in Generate Biomedicines, Inc. is owned by the company. AMERIPRISE FINANCIAL INC owns 87.34K shares valued at $1.09M, which translates its holding of 0.07% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	MILLENNIUM MANAGEMENT LLC	0.29%	376.89K	4.71M	376.89K	+100.00%
Mar 31, 2026	AMERIPRISE FINANCIAL INC	0.07%	87.34K	1.09M	87.34K	+100.00%
Mar 31, 2026	BALYASNY ASSET MANAGEMENT L.P.	0.06%	79.49K	993.61K	79.49K	+100.00%
Mar 31, 2026	MANUFACTURERS LIFE INSURANCE COMPANY, THE	0.06%	74.31K	928.9K	74.31K	+100.00%
Mar 31, 2026	PRICE T ROWE ASSOCIATES INC /MD/	1.65%	2.11M	26.37M	2.11M	+100.00%
Mar 31, 2026	BAKER BROS. ADVISORS LP	1.11%	1.42M	17.8M	1.42M	+100.00%
Mar 31, 2026	HARVARD MANAGEMENT CO INC	0.87%	1.11M	13.89M	1.11M	+100.00%
Mar 31, 2026	NVIDIA CORP	0.65%	833.33K	10.42M	833.33K	+100.00%
Mar 31, 2026	SIREN, L.L.C.	0.57%	736.1K	9.2M	736.1K	+100.00%
Mar 31, 2026	DAVERN CAPITAL PARTNERS, LP	0.46%	591.8K	7.4M	591.8K	+100.00%
Mar 31, 2026	ARCH VENTURE MANAGEMENT, LLC	1.52%	1.94M	24.31M	1.94M	+100.00%
Mar 31, 2026	HARBOURVEST PARTNERS LLC	1.34%	1.72M	21.53M	1.72M	+100.00%
Mar 31, 2026	ALYESKA INVESTMENT GROUP, L.P.	0.39%	500K	6.25M	500K	+100.00%
Mar 31, 2026	ARK INVESTMENT MANAGEMENT LLC	0.39%	498.41K	6.23M	498.41K	+100.00%
Mar 31, 2026	SUMITOMO MITSUI TRUST HOLDINGS, INC.	0.03%	40.34K	504.3K	40.34K	+100.00%
Mar 31, 2026	FLAGSHIP PIONEERING INC.	48.89%	62.67M	783.41M	62.67M	+100.00%
Mar 31, 2026	FMR LLC	3.29%	4.22M	52.72M	4.22M	+100.00%
Mar 31, 2026	CAPITAL WORLD INVESTORS	3.12%	4M	50.05M	4M	+100.00%
Mar 31, 2026	BRAIDWELL LP	2.8%	3.59M	44.91M	3.59M	+100.00%
Mar 31, 2026	JPMORGAN CHASE & CO	2.3%	2.95M	33.92M	2.95M	+100.00%
Mar 31, 2026	ALBION FINANCIAL GROUP /UT	0%	4.85K	60.68K	4.85K	+100.00%
Mar 31, 2026	SUMITOMO MITSUI TRUST GROUP, INC.	0.03%	40.34K	504.3K	40.34K	+100.00%
Mar 31, 2026	UBS GROUP AG	0.28%	356.7K	4.46M	356.7K	+100.00%
Mar 31, 2026	AFFINITY ASSET ADVISORS, LLC	0.27%	350K	4.38M	350K	+100.00%
Mar 31, 2026	MORGAN STANLEY	0.26%	337.3K	4.22M	337.3K	+100.00%
Mar 31, 2026	EXODUSPOINT CAPITAL MANAGEMENT, LP	0.24%	311.99K	3.9M	311.99K	+100.00%
Mar 31, 2026	CENTERBOOK PARTNERS LP	0.21%	266.81K	3.34M	266.81K	+100.00%
Mar 31, 2026	SPHERA FUNDS MANAGEMENT LTD.	0.14%	185K	2.31M	185K	+100.00%
Mar 31, 2026	GOLDMAN SACHS GROUP INC	0.13%	170.7K	2.13M	170.7K	+100.00%
Mar 31, 2026		0.1%	131.32K	1.64M	131.32K	+100.00%
Mar 31, 2026	SEVEN GRAND MANAGERS, LLC	0.1%	125K	1.56M	125K	+100.00%
Mar 31, 2026	JANE STREET GROUP, LLC	0.1%	123.37K	1.54M	123.37K	+100.00%
Mar 31, 2026	GEODE CAPITAL MANAGEMENT, LLC	0.09%	118.24K	1.48M	118.24K	+100.00%
Mar 31, 2026	LMR PARTNERS LLP	0.08%	100K	1.25M	100K	+100.00%
Mar 31, 2026	SILVERARC CAPITAL MANAGEMENT, LLC	0.08%	100K	1.25M	100K	+100.00%
Mar 31, 2026	NIKKO ASSET MANAGEMENT AMERICAS, INC.	0.03%	40.34K	499.46K	40.34K	+100.00%
Mar 31, 2026	SQUAREPOINT OPS LLC	0.03%	37.2K	465.04K	37.2K	+100.00%
Mar 31, 2026	BANK OF AMERICA CORP /DE/	0.03%	34.2K	427.45K	34.2K	+100.00%
Mar 31, 2026	FEDERATED HERMES, INC.	0.02%	30K	375K	30K	+100.00%
Mar 31, 2026	TUDOR INVESTMENT CORP ET AL	0.02%	23.83K	297.91K	23.83K	+100.00%
Mar 31, 2026	IQ EQ FUND MANAGEMENT (IRELAND) LTD	0.02%	19.2K	240.04K	19.2K	+100.00%
Mar 31, 2026	D. E. SHAW & CO., INC.	0.07%	95K	1.19M	95K	+100.00%
Mar 31, 2026	Y-INTERCEPT (HONG KONG) LTD	0.01%	18.36K	229.53K	18.36K	+100.00%
Mar 31, 2026	VANGUARD FIDUCIARY TRUST CO	0.01%	17.46K	218.2K	17.46K	+100.00%
Mar 31, 2026	HUDSON BAY CAPITAL MANAGEMENT LP	0.01%	16.68K	208.48K	16.68K	+100.00%
Mar 31, 2026	BREVAN HOWARD CAPITAL MANAGEMENT LP	0.01%	12.57K	157.14K	12.57K	+100.00%
Mar 31, 2026	DIAMETRIC CAPITAL, LP	0.01%	10.5K	131.21K	10.5K	+100.00%
Mar 31, 2026	PARALLEL ADVISORS, LLC	0%	5.55K	69.38K	5.55K	+100.00%
Mar 31, 2026	BARCLAYS PLC	0.06%	70.89K	886.18K	70.89K	+100.00%
Mar 31, 2026	HRT FINANCIAL LP	0.05%	58.76K	734K	58.76K	+100.00%
Mar 31, 2026	QUBE RESEARCH & TECHNOLOGIES LTD	0.04%	50.22K	627.76K	50.22K	+100.00%
Mar 31, 2026	TD ASSET MANAGEMENT INC	0.03%	42.87K	535.83K	42.87K	+100.00%

GENB Stock Ownership Breakdown